SOMA Research

HPLC vs Mass Spectrometry: Why a Peptide CoA Needs Both

Every Certificate of Analysis worth reading reports two tests: HPLC and mass spectrometry. They are not redundant and they are not interchangeable. They answer two different questions, and a certificate carrying only one of them leaves the other question open. This guide explains what each measures, what each is blind to, and how to read the four possible combinations of results.

SOMA Research supplies research-use-only compounds for laboratory use. Nothing here is medical advice.

The two questions

HPLC Mass spectrometry
Answers How much of this is the target? Is this the target?
Measures Purity, as % of total peak area Identity, as molecular mass
Separates by Hydrophobicity Mass-to-charge ratio
Blind to Identity; anything co-eluting Anything with the same mass

Purity and identity are independent properties. A sample can be 99.8% pure and be 99.8% the wrong molecule. A sample can have exactly the right mass and be half junk. Neither test detects the other’s failure.

What HPLC actually does

Reversed-phase HPLC pushes the sample through a column packed with a hydrophobic stationary phase, usually C18 silica, while the mobile phase shifts gradually from mostly water to mostly acetonitrile. Hydrophilic species come off early; hydrophobic ones are retained and come off later. A detector at the column outlet records absorbance as material elutes, producing peaks.

Purity is reported as the target peak’s area as a percentage of all peak area. Three things about that number are worth knowing.

The detection wavelength matters

  • 214 nm or 220 nm detects the peptide bond itself. Every peptide absorbs here regardless of sequence, which makes it the appropriate choice for peptide purity.
  • 280 nm detects aromatic side chains — tryptophan, tyrosine, and weakly phenylalanine. A peptide without aromatics is close to invisible at 280 nm.

This is a practical check. BPC-157 (GEPPPGKPADDAGLV) contains no tryptophan or tyrosine. KPV contains none either. A purity figure measured at 280 nm for either compound is not measuring the peptide meaningfully. If a certificate states the wavelength — and it should — check it suits the sequence.

Area percent is not mass percent

Peak area depends on how strongly a species absorbs, not on how much of it there is. Two compounds at identical concentration give different peak areas if their absorptivities differ. For closely related impurities — a deletion sequence missing one residue — the difference is small and area% is a good proxy. For a structurally unrelated contaminant it may not be. “99.5% by area” is a statement about the chromatogram, not a weight fraction.

Resolution sets the ceiling on what the number means

HPLC can only report impurities it separates. Anything co-eluting with the target is counted as target. A short or shallow gradient produces fewer, broader peaks and a flattering purity figure; a long well-resolved gradient reveals more and reports lower. A higher purity number can indicate a worse method. This is why a chromatogram image matters more than the percentage beneath it — baseline resolution and peak shape are visible in the trace and invisible in the number.

What mass spectrometry actually does

Electrospray ionisation sprays the sample from solution, producing gas-phase ions that typically carry several charges. The instrument measures mass-to-charge ratio, so a single peptide appears as a series of peaks at different charge states; software deconvolutes those into one molecular mass.

Two conventions to be aware of when comparing an observed figure to a theoretical one:

  • Average mass uses the natural isotopic abundance of each element. This is the figure quoted for most peptides — for example approximately 1,419.5 for BPC-157.
  • Monoisotopic mass uses only the lightest isotope of each element. For a peptide of a few thousand daltons the two differ by roughly one to two units.

A small discrepancy between observed and expected can be a convention mismatch rather than a wrong compound.

The blind spot that matters most: isomers

Mass spectrometry cannot distinguish molecules of identical mass. For peptides this is not theoretical — several of the most important synthesis and degradation products are exact-mass isomers of the target:

  • Racemisation. A residue that epimerises from L to D has exactly the same mass. The peptide is chemically distinct and may behave differently, and MS cannot see it at all.
  • Aspartimide and isoaspartate. Aspartic acid can cyclise to aspartimide and reopen as isoaspartate, shifting the backbone through the side chain. Same atoms, same mass, different molecule. This is a known issue for sequences with Asp-Gly or Asp-Asp motifs — BPC-157 has an adjacent Asp-Asp pair.
  • Scrambled sequences. Any rearrangement of the same residues has the same mass.

Every one of these is invisible to MS and visible to a well-resolved HPLC trace, because isomers generally differ in hydrophobicity enough to shift retention. This is the strongest single argument for requiring both tests: the failure modes MS misses are precisely the ones chromatography catches.

The reverse holds too. HPLC cannot tell you what a peak is. A pure preparation of the wrong peptide gives a beautiful chromatogram.

The four combinations

Mass correct Mass wrong
HPLC clean Right molecule, clean preparation. What you want. A pure preparation of something else. The most dangerous result, because the purity figure looks excellent.
HPLC poor Right molecule in a dirty preparation. The impurities are usually synthesis-related. Wrong molecule and dirty. Obvious, at least.

Only the top-left cell is acceptable, and you cannot locate yourself in this table with one test. A certificate reporting only mass cannot distinguish the two cells in the left column. A certificate reporting only purity cannot distinguish the two cells in the top row.

The third number: peptide content

Neither test above tells you how much peptide is in the vial. Synthetic peptides are supplied as salts — usually acetate or TFA — and carry bound water. A vial labelled 10 mg typically contains meaningfully less than 10 mg of peptide.

Peptide content (or net peptide content) is a separate determination, usually by amino acid analysis or nitrogen determination, reporting what fraction of the weighed mass is actually peptide. It is routinely confused with HPLC purity and the two are unrelated: a sample can be 99% pure and 80% peptide content, meaning 99% of the peptide present is the target and peptide is 80% of what you weighed.

Any molarity calculation needs the content figure, not the label mass. The effect is proportionally largest for small peptides, where the counter-ion is a bigger share of total mass.

What a complete certificate shows

  • The chromatogram itself, not only a percentage — so peak shape, baseline and resolution can be judged.
  • Method conditions: column, gradient, and detection wavelength.
  • The mass spectrum, with observed and theoretical mass stated together.
  • Peptide content reported separately from purity.
  • A lot number matching the vial, and a test date after the manufacture date.
  • A named testing laboratory.

Red flags: a purity percentage with no chromatogram; a mass with no spectrum; “≥99%” with no method stated; a certificate not tied to a specific lot. Our Certificate of Analysis guide walks through each field, and measured figures for every SOMA lot are published in the CoA library.

Research use only

SOMA Research compounds are supplied for laboratory use by qualified researchers and institutions. They are not manufactured to pharmaceutical standards, have not been approved by the FDA for any use, and must not be used in or on humans or animals.